Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution Assessment

被引:144
作者
Debaene, Francois [1 ,2 ]
Boeuf, Amandine [1 ,3 ]
Wagner-Rousset, Elsa [3 ]
Colas, Olivier [3 ]
Ayoub, Daniel [3 ]
Corvaia, Nathalie [3 ]
Van Dorsselaer, Alain [2 ]
Beck, Alain [3 ]
Cianferani, Sarah [2 ]
机构
[1] Univ Strasbourg, BioOrgan Mass Spectrometry Lab LSMBO, IPHC, F-67087 Strasbourg, France
[2] CNRS, IPHC, UMR7178, F-67087 Strasbourg, France
[3] CIPF, F-74164 St Julien En Genevois, France
关键词
MOBILITY-MASS-SPECTROMETRY; ION-MOBILITY; MONOCLONAL-ANTIBODIES; ELECTROSPRAY IONIZATION; THERAPEUTIC ANTIBODIES; INTACT ANTIBODIES; PROTEIN COMPLEXES; CANCER-THERAPY; DISSOCIATION; DYNAMICS;
D O I
10.1021/ac502593n
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Antibody drug conjugates (ADCs) are macromolecules composed of cytotoxic drugs covalently attached via a conditionally stable linker to monoclonal antibodies (mAbs). ADCs are among the most promising next generation of empowered mAbs foreseen to treat cancers. Compared to naked mAbs, ADCs have an increased level of complexity as the heterogeneity of conjugation cumulates with the inherent microvariability of the biomolecule. An increasing need underlying ADC's development and optimization is to improve its analytical and bioanalytical characterization by assessing three main ADC quality attributes: drug distribution, amount of naked antibody, and average drug to antibody ratio (DAR). Here, the analytical potential of native mass spectrometry (MS) and native ion mobility MS (IM-MS) is compared to hydrophobic interaction chromatography (HIC), the reference method for quality control of interchain cysteinyl-linked ADCs. Brentuximab vedotin, first in class and gold standard, was chosen for a proof of principle. High resolution native MS provided accurate mass measurement (<30 ppm) of intact ADCs together with average DAR and drug distribution, confirming the unique ability of native MS for simultaneous detection of mixtures of covalent and noncovalent products. Native IM-MS was next used for the first time to characterize an ADC. IM-MS evidenced ADC multiple drug loading, collisional cross sections measurement of each payload species attesting slight conformational changes. A semiquantitative interpretation of IM-MS data was developed to directly extrapolate average DAR and DAR distribution. Additionally, HIC fractions were collected and analyzed by native MS and IM-MS, assessing the interpretation of each HIC peak. Altogether, our results illustrate how native MS and IM-MS can rapidly assess ADC structural heterogeneity and how easily these methods can be implemented into MS workflows for in-depth ADC analytical characterization.
引用
收藏
页码:10674 / 10683
页数:10
相关论文
共 49 条
  • [1] [Anonymous], 2013, MABS-AUSTIN, DOI DOI 10.4161/MABS.27005
  • [2] Atmanene Cedric, 2013, Methods Mol Biol, V988, P243, DOI 10.1007/978-1-62703-327-5_16
  • [3] Exploring Key Parameters to Detect Subtle Ligand-Induced Protein Conformational Changes Using Traveling Wave Ion Mobility Mass Spectrometry
    Atmanene, Cedric
    Petiot-Becard, Stephanie
    Zeyer, Denis
    Van Dorsselaer, Alain
    Hannah, Valerie Vivat
    Sanglier-Cianferani, Sarah
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (11) : 4703 - 4710
  • [4] Extending Mass Spectrometry Contribution to Therapeutic Monoclonal Antibody Lead Optimization: Characterization of Immune Complexes Using Noncovalent ESI-MS
    Atmanene, Cedric
    Wagner-Rousset, Elsa
    Malissard, Martine
    Chol, Bertrand
    Robert, Alain
    Corvaia, Nathalie
    Van Dorsselaer, Alain
    Beck, Alain
    Sanglier-Cianferani, Sarah
    [J]. ANALYTICAL CHEMISTRY, 2009, 81 (15) : 6364 - 6373
  • [5] Resolving Disulfide Structural Isoforms of IgG2 Monoclonal Antibodies by Ion Mobility Mass Spectrometry
    Bagal, Dhanashri
    Valliere-Douglass, John F.
    Balland, Alain
    Schnier, Paul D.
    [J]. ANALYTICAL CHEMISTRY, 2010, 82 (16) : 6751 - 6755
  • [6] Antibody-drug conjugates Present and future
    Beck, Alain
    Reichert, Janice M.
    [J]. MABS, 2014, 6 (01) : 15 - 17
  • [7] Analytical characterization of biosimilar antibodies and Fc-fusion proteins
    Beck, Alain
    Diemer, Helene
    Ayoub, Daniel
    Debaene, Francois
    Wagner-Rousset, Elsa
    Carapito, Christine
    Van Dorsselaer, Alain
    Sanglier-Cianferani, Sarah
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2013, 48 : 81 - 95
  • [8] Beck A, 2010, DISCOV MED, V10, P329
  • [9] Characterization of Therapeutic Antibodies and Related Products
    Beck, Alain
    Wagner-Rousset, Elsa
    Ayoub, Daniel
    Van Dorsselaer, Alain
    Sanglier-Cianferani, Sarah
    [J]. ANALYTICAL CHEMISTRY, 2013, 85 (02) : 715 - 736
  • [10] Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
    Beck, Alain
    Sanglier-Cianferani, Sarah
    Van Dorsselaer, Alain
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (11) : 4637 - 4646